プライマリケア設定における、簡潔で動機づけ面接に基づく致死的手段安全カウンセリング介入の実装戦略の開発とパイロット実施 (CDA-2)
一次医療機関における簡潔で動機づけ面接に基づいた致死的手段安全カウンセリング介入の実施戦略の開発と試験的導入
Suicide prevention remains a significant priority and nearly three-quarters of Veteran suicides result from firearm injury. Since access to lethal means of self-harm increases the risk of injury, the VA/DoD Clinical Practice Guidelines recommend that Veterans with elevated suicide risk receive lethal means safety (LMS) counseling to reduce access to lethal means, including firearms. However, no LMS counseling interventions have been tested within VA. Thus, the aim of this study is to conduct a pilot randomized controlled trial to evaluate the feasibility and acceptability of a tailored LMS counseling intervention compared to an active control condition.
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
詳細な説明
This is a pilot randomized controlled trial of up to 50 Veterans to assess the feasibility and acceptability of a LMS intervention and testing procedures.
研究の種類
研究の種類
入学 (推定)
入学
段階
段階
- 適用できない
連絡先と場所
研究連絡先
研究連絡先
- 名前:Steve Martino, PhD
- 電話番号:2468 (203) 932-5711
- メール:Steve.Martino@va.gov
研究連絡先のバックアップ
- 名前:Frances Aunon, PhD MS
- 電話番号:7894 (203) 932-5711
- メール:Frances.Aunon@va.gov
研究場所
-
-
Connecticut
-
West Haven、Connecticut、アメリカ、06516-2770
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT
-
コンタクト:
- Steve Martino, PhD
- 電話番号:2468 (203) 932-5711
- メール:Steve.Martino@va.gov
-
コンタクト:
- Kimberly L Selander, MA
- 電話番号:(203) 932-5711
- メール:Kimberly.Selander@va.gov
-
主任研究者:
- Frances Aunon, PhD MS
-
-
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
For Veterans:
- Has access to a firearm
- Referred to Primary Care Mental Health Integration (PCMHI) care
For clinicians (delivering intervention):
- Deliver care in Primary Care Mental Health Integration (PCMHI)
- Trained in RAMP and study procedures
Exclusion Criteria:
For Veterans:
- Unable to consent due to cognitive impairment, severity of illness (including psychiatric symptoms), intoxication with drugs and/or alcohol
- Unreliable telephone access
- Inability to read English or communicate in spoken and written English
For clinicians (delivering intervention):
- Did not participate in training
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:防止
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:独身
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
アクティブコンパレータ:Active control
The control condition will entail a 5-minute review of a pamphlet on suicide prevention with the Primary Care Mental Health Integration (PCMHI) clinician. This pamphlet is produced by the Veteran's Crisis Line and is widely available on the OSP suicide prevention website as a VHA resource. This condition will control for time and attention, subject matter, mode of delivery, and setting. |
The control condition will entail a 5-minute review of a pamphlet on suicide prevention with the Primary Care Mental Health Integration (PCMHI) clinician. This pamphlet is produced by the Veteran's Crisis Line and is widely available on the OSP suicide prevention website as a VHA resource. This condition will control for time and attention, subject matter, mode of delivery, and setting. |
|
実験的:RAMP
Participants randomized to the intervention condition will receive a brief, motivational interviewing-based intervention called RAMP (Raise the subject, Assess current storage, Motivate change, and Plan next steps) in the context of their clinical care. RAMP incorporates evidence-informed intervention components to facilitate secure firearm storage |
Participants randomized to the intervention condition will receive a brief, motivational interviewing-based intervention called RAMP (Raise the subject, Assess current storage, Motivate change, and Plan next steps) in the context of their clinical care. RAMP incorporates evidence-informed intervention components to facilitate secure firearm storage |
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Screening
時間枠:through study completion, approximately 2 years
|
Investigators will assess the number of new Primary Care Mental Health Integration (PCMHI) patients seen in PCMHI and the number who were approached about potential study participation per month |
through study completion, approximately 2 years
|
|
Recruitment
時間枠:through study completion, approximately 2 years
|
Investigators will track the number of eligible Veterans who enrolled in the study per month |
through study completion, approximately 2 years
|
|
Retention
時間枠:approximately 30 days
|
Investigators will calculate the number of Veterans who received RAMP who were willing to complete immediate and one-month follow up assessments. |
approximately 30 days
|
|
Assessment of behavioral outcomes
時間枠:approximately 30 days
|
Investigators will assess the percentage of participants who completed behavioral outcome measures within the time allotted at each timepoint |
approximately 30 days
|
|
Veteran acceptability - Theoretical Framework of Acceptability
時間枠:At immediate follow up, within approximately 2 weeks of intervention
|
Investigators will assess Veteran acceptability using the eight Likert-style items from the Theoretical Framework of Acceptability questionnaire, which assess seven component constructs of acceptability including Veteran's experience of the lethal means safety intervention. Each item has 5 answer options (1-5) on a Likert Scale. Score range is 8 to 40, with a higher score indicating more higher reported acceptability. |
At immediate follow up, within approximately 2 weeks of intervention
|
|
Veteran acceptability - Experience and Satisfaction with intervention
時間枠:At immediate follow up, within approximately 2 weeks of intervention
|
Investigators will conduct qualitative evaluation of the participant's experience and satisfaction receiving the intervention. |
At immediate follow up, within approximately 2 weeks of intervention
|
|
Clinician acceptability - Theoretical Framework of Acceptability
時間枠:at 50% enrollment (approximately 1 year) and 100% enrollment (approximately 2 years)
|
Investigators will invite clinicians to respond to the eight-item Theoretical Framework of Acceptability questionnaire eliciting clinician acceptability of the lethal means safety intervention. Each item has 5 answer options (1-5) on a Likert Scale. Score range is 8 to 40, with a higher score indicating more higher reported acceptability. |
at 50% enrollment (approximately 1 year) and 100% enrollment (approximately 2 years)
|
|
Clinician acceptability - Negative impact
時間枠:at 50% enrollment (approximately 1 year) and 100% enrollment (approximately 2 years)
|
Investigators will assess to what extent Primary Care Mental Health Integration (PCMHI) clinicians agree that study recruitment negatively impacted clinical care, using Likert-type items where '1' indicates "strongly disagree" and '5' indicates "strongly agree." For those responding >3 ("don't know"), an open-ended question will elicit detailed information (e.g., interfered with delivery of clinical care, led to Veteran frustration). |
at 50% enrollment (approximately 1 year) and 100% enrollment (approximately 2 years)
|
協力者と研究者
捜査官
捜査官
- 主任研究者:Frances Aunon, PhD MS、VA Connecticut Healthcare System West Haven Campus, West Haven, CT
研究記録日
主要日程の研究
研究開始 (推定)
研究開始
一次修了 (推定)
一次修了
研究の完了 (推定)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
その他の研究ID番号
- HSR4-001-24W
- 1IK2RD000503-01A2 (米国 NIH グラント/契約)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
米国で製造され、米国から輸出された製品。
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。